Advertisement

Polyneuropathy in Patients Undergoing a Neuromuscular Junction Blockade

  • D. Østergaard
Conference paper

Abstract

Neuromuscular blocking drugs (NMBD) are used extensively in many intensive care units (ICU) in the USA, whereas in Europe they are less frequently used [1, 2]. Often these drugs are used without monitoring the neuromuscular block quantitatively. The NMBD are used in doses which exceed by far those used in the operating room and for a considerably longer period of time in patients who are very different from the healthier patients undergoing general anaesthesia. Most recommendations for the use of NMBD are extrapolated from the short-term use in the operating room and this information is not applicable to the long-term use in critically ill patients. The ICU patients are often haemodynamically unstable: they have reduced organ functions or even organ failure and often receive concomitant medication. Furthermore these patients are immobilised, which might have consequences for the neuromuscular block. The importance of the different structure and pharmacokinetics of the individual NMBD is of special importance in the ICU patients. The long-term use of NMBD is associated with many difficulties and serious complications. Many case reports describe persistent paralysis after long-term use of NMBD to facilitate mechanical ventilation. The incidence of prolonged paralysis is estimated at 20% for the patient receiving NMBD for more than 6 days and 15–40% in patients with asthma receiving NMBD and corticosteroids [1]. It has been suggested that reducing the amount of NMBD administered by monitoring the neuromuscular transmission may decrease the risk of prolonged paralysis.

Keywords

Intensive Care Unit Patient Neuromuscular Block Adductor Pollicis Plasma Cholinesterase Critical Illness Polyneuropathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Miller RD (1995) Use of neuromuscular blocking drugs in the intensive care unit patients. Editorial. Anesth Analg 81:1–2Google Scholar
  2. 2.
    Bion JF, Ledingham JI (1987) Sedation in intensive care — a postal survey. Intensive Care Med 13:215–216PubMedGoogle Scholar
  3. 3.
    Meistelman C, Plaud B (1997) Neuromuscular blockade: is it still useful in the ICU? Eur J Anaesth [Suppl 15]:53–56CrossRefGoogle Scholar
  4. 4.
    Hsiang JK, Chesnut RM, Crisp CB et al (1994) Early, routine paralysis for intracranial pressure control in severe head injury: Is it necessary? Crit Care Med 22:1471–1476PubMedCrossRefGoogle Scholar
  5. 5.
    Segredo V, Caldwell JE, Matthay M et al (1992) Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 327:524–526PubMedCrossRefGoogle Scholar
  6. 6.
    Gooch JL, Suchyta MR, Balbierz JM et al (1991) Prolonged paralysis after treatment with neuromuscular blocking agents. Crit Care Med 19:1125–1131PubMedCrossRefGoogle Scholar
  7. 7.
    Meyer KC, Prielipp RC, Grossman JE et al (1994) Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 78:772–774PubMedCrossRefGoogle Scholar
  8. 8.
    Davis NA, Rodgers JE, Gonzales ER et al (1998) Prolonged weakness after cisatracurium infusion: A case report. Crit Care Med 26:1290–1292PubMedCrossRefGoogle Scholar
  9. 9.
    Nates JL, Cooper DJ, Day B et al (1997) Acute weakness syndromes in critically ill patients — A reappraisal. Anesth Intens Care 25:502–513Google Scholar
  10. 10.
    Hogue CW, Ward JM, Itani S et al (1992) Tolerance and upregulation of acetylcholine receptors following chronic infusion of d-tubocurarine. J Appl Physiol 72:1326–1331PubMedGoogle Scholar
  11. 11.
    Berg H (1997) Is residual neuromuscular block following pancuronium a risk factor for postoperative pulmonary complications? Acta Anaesthesiol Scand 41[Suppl]: 156–158CrossRefGoogle Scholar
  12. 12.
    Sparr HJ, Wierda MKH, Proost JH et al (1997) Pharmacodynamics and pharmacokinetics of rocuronium in intensive care patients. Br J Anaesth 78:267–273PubMedCrossRefGoogle Scholar
  13. 13.
    Prielipp RC, Courain DB, Scruderi PE et al (1995) Comparison of the infusion requirements and recovery profile of vecuronium and cisatracurium 51W89 in intensive care unit patients. AnesthAnalg 81:3–12Google Scholar
  14. 14.
    Murray MJ, Coursin DB, Scuderi PE et al (1995) Double-blind, randomised, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular blocking agents. Crit Care Med 23:450–458PubMedCrossRefGoogle Scholar
  15. 15.
    Tobias JD, Lynch A, McDuffee A et al (1994) Pancuronium infusion for the neuromuscular block in children in paediatric intensive care units. Anesth Analg 81:13–16CrossRefGoogle Scholar
  16. 16.
    Katz RL (1967) Neuromuscular effects of d-tubocurarine, edrophonium and neostigmine in man. Anesthesiology 28:327–336PubMedCrossRefGoogle Scholar
  17. 17.
    Khuehln-Brady KS, Reitslatter B, Sclager A et al (1994) Long-term administration of pancuronium and pipecuronium in the intensive care unit. Anesth Analg 78:1082–1086Google Scholar
  18. 18.
    Frankel H, Jeng J, Tilly E et al (1996) The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit. Am Surg 62:503–506PubMedGoogle Scholar
  19. 19.
    Rudis MI, Sikora CA, Angus E et al (1997) A prospective, randomised, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med 25:575–583PubMedCrossRefGoogle Scholar
  20. 20.
    Donati F, Meistelman C, Plaud B (1990) Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi and the adductor pollicis muscles. Anesthesiology 73:870–875PubMedCrossRefGoogle Scholar
  21. 21.
    Viby-Mogensen J (1993) Monitoring neuromuscular function in the Intensive Care Unit. Intensive Care Med 19:S74–S79PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • D. Østergaard
    • 1
  1. 1.Dept. of AnaesthesiologyGentofte University HospitalCopenhagenDenmark

Personalised recommendations